Cargando…

Chronic thromboembolic pulmonary hypertension complicating long-term cyproterone acetate therapy

Detalles Bibliográficos
Autores principales:	Montani, David, Bertoletti, Laurent, Chaumais, Marie-Camille, Perrin, Swanny, Fabre, Dominique, Chaouat, Ari, Jaïs, Xavier, Simonneau, Gérald, Humbert, Marc
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	European Respiratory Society 2014
Materias:	Letters
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9487569/ https://www.ncbi.nlm.nih.gov/pubmed/24881082 http://dx.doi.org/10.1183/09059180.00005913

Ejemplares similares

French experience of balloon pulmonary angioplasty for chronic thromboembolic pulmonary hypertension
por: Brenot, Philippe, et al.
Publicado: (2019)

Sex and gender in pulmonary arterial hypertension
por: Cheron, Céline, et al.
Publicado: (2021)

Pulmonary hypertension associated with busulfan
por: Hagenburg, Jean, et al.
Publicado: (2021)

Pulmonary Hypertension Complicating Fibrosing Mediastinitis
por: Seferian, Andrei, et al.
Publicado: (2015)

Voltammetric Determination of Cyproterone Acetate in Pharmaceutical Preparations
por: El-Enany, Nahed, et al.
Publicado: (2010)

Histomolecular characterization of intracranial meningiomas developed in patients exposed to high-dose cyproterone acetate: an antiandrogen treatment
por: Portet, Sylvain, et al.
Publicado: (2019)

A rare case of sarcoidosis-associated pulmonary hypertension in a patient exposed to silica
por: Bourlier, Delphine, et al.
Publicado: (2016)

Acute decompensated pulmonary hypertension
por: Savale, Laurent, et al.
Publicado: (2017)

External validation of a refined four-stratum risk assessment score from the French pulmonary hypertension registry
por: Boucly, Athénaïs, et al.
Publicado: (2022)

Cyproterone acetate acts as a disruptor of the aryl hydrocarbon receptor
por: Chen, Chih-Shou, et al.
Publicado: (2021)

Increased oxidative stress and severe arterial remodeling induced by permanent high-flow challenge in experimental pulmonary hypertension
por: Dorfmüller, Peter, et al.
Publicado: (2011)

N-acetylcysteine improves established monocrotaline-induced pulmonary hypertension in rats
por: Chaumais, Marie-Camille, et al.
Publicado: (2014)

Pulmonary arterial hypertension
por: Montani, David, et al.
Publicado: (2013)

Screening for pulmonary arterial hypertension in systemic sclerosis
por: Weatherald, Jason, et al.
Publicado: (2019)

A prospective randomised controlled trial of tamoxifen and cyproterone acetate in pancreatic carcinoma.
por: Keating, J. J., et al.
Publicado: (1989)

Unilateral proptosis and blindness caused by meningioma in a patient treated with cyproterone acetate
por: Sys, Celine, et al.
Publicado: (2015)

SAT397 A Low Dose Cyproterone Acetate In Feminizing Hormone Treatment
por: Korpaisarn, Sira, et al.
Publicado: (2023)

Cyproterone acetate or spironolactone in lowering testosterone concentrations for transgender individuals receiving oestradiol therapy
por: Angus, Lachlan, et al.
Publicado: (2019)

A systematic review and meta-analysis of the association between cyproterone acetate and intracranial meningiomas
por: Lee, Keng Siang, et al.
Publicado: (2022)

Double-Blind, Placebo-Controlled Trial of Cyproterone Acetate to Prevent Flare-Up Effect on Dogs Implanted With Deslorelin
por: Masson, Sylvia, et al.
Publicado: (2021)

Factors predicting outcome after pulmonary endarterectomy
por: Tromeur, Cécile, et al.
Publicado: (2018)

Pulmonary hypertension associated with diazoxide: the SUR1 paradox
por: Montani, David, et al.
Publicado: (2023)

The pathophysiology of chronic thromboembolic pulmonary hypertension
por: Simonneau, Gérald, et al.
Publicado: (2017)

Pulmonary Vascular Resistance in Pulmonary Arterial Hypertension: La Pièce de Résistance?
por: Weatherald, Jason, et al.
Publicado: (2021)

Identifying new drugs associated with pulmonary arterial hypertension: A WHO pharmacovigilance database disproportionality analysis
por: Hlavaty, Alex, et al.
Publicado: (2022)

The changing landscape of chronic thromboembolic pulmonary hypertension management
por: Madani, Michael, et al.
Publicado: (2017)

SUN-042 Low Dose Cyproterone Acetate for the Treatment of Transgender Women - a Retrospective Study
por: Even-Zohar, Naomi, et al.
Publicado: (2020)

The clinical activity of cyproterone acetate in advanced ovarian carcinoma. A London Gynaecology Oncology Group Study.
por: Thompson, P., et al.
Publicado: (1991)

Regression of Giant Olfactory Groove Meningioma and Complete Visual Acuity Recovery after Discontinuation of Cyproterone Acetate
por: Bernat, Anne Laure, et al.
Publicado: (2018)

Toward a Lowest Effective Dose of Cyproterone Acetate in Trans Women: Results From the ENIGI Study
por: Kuijpers, Suzanne M E, et al.
Publicado: (2021)

Clinical phenotypes and survival of pre-capillary pulmonary hypertension in systemic sclerosis
por: Launay, David, et al.
Publicado: (2018)

Screening for pulmonary arterial hypertension in adults carrying a BMPR2 mutation
por: Montani, David, et al.
Publicado: (2021)

Pulmonary hypertension associated with neurofibromatosis type 1
por: Jutant, Etienne-Marie, et al.
Publicado: (2018)

Lung Ventilation/Perfusion Scintigraphy for the Screening of Chronic Thromboembolic Pulmonary Hypertension (CTEPH): Which Criteria to Use?
por: Le Pennec, Romain, et al.
Publicado: (2022)

Venous thromboembolism and COVID-19
por: Bertoletti, L., et al.
Publicado: (2020)

Flutamide versus a cyproterone acetate-ethinyl estradiol combination in moderate acne: a pilot randomized clinical trial
por: Adalatkhah, Hassan, et al.
Publicado: (2011)

Cyproterone Acetate Mediates IRE1α Signaling Pathway to Alleviate Pyroptosis of Ovarian Granulosa Cells Induced by Hyperandrogen
por: Zhang, Yan, et al.
Publicado: (2022)

An emerging phenotype of pulmonary arterial hypertension patients carrying SOX17 variants
por: Montani, David, et al.
Publicado: (2022)

Sequential combination therapy with parenteral prostacyclin in BMPR2 mutations carriers
por: Boucly, Athénaïs, et al.
Publicado: (2022)

Quality of life in patients with chronic thromboembolic pulmonary hypertension
por: Mathai, Stephen C., et al.
Publicado: (2016)

Cannot write session to /tmp/vufind_sessions/sess_acn3u037s72gh9kenhs383abr4